Source:http://linkedlifedata.com/resource/pubmed/id/18407102
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-4-14
|
pubmed:abstractText |
Recently discovered nonpeptide angiotensin II receptor antagonists represent a new class of potential drugs for the treatment of hypertension and congestive heart failure. Further, these antagonists have been successfully used as selective research tools for physiologic studies of angiotensin H and defining angiotensin II receptor subtypes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1043-2760
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-7
|
pubmed:year |
1992
|
pubmed:articleTitle |
Angiotensin II receptor antagonists and receptor subtypes.
|
pubmed:affiliation |
Du Pont Merck Pharmaceutical Company, Experimental Station, Wilmington, DE 19880-0400, USA.
|
pubmed:publicationType |
Journal Article
|